Local Institution - 102

Seattle, Washington 98124

1 studies enrolling now · 4 studies all time

What they study most

Autoimmune Hemolytic Anemia, Chronic Immune Thrombocytopenia, Leukemia, Myeloid, Acute, Lymphoma, Non-Hodgkin, Multiple Myeloma

Studies at this site

• Study of Zola-cel (BMS-986353), in Participants With Autoimmune Cytopenia (Breakfree-AiCE) — Starting soon
• A Dose Finding Study of CC-96673 in Participants With Relapsed or Refractory Non-Hodgkin's Lymphoma — Stopped early
• A Study of CC-99712, a BCMA Antibody-Drug Conjugate, in Participants With Relapsed and Refractory Multiple Myeloma — Stopped early
• A Safety and Efficacy Study of CC-90009 Combinations in Subjects With Acute Myeloid Leukemia — Stopped early